I hope that someone who is following the financials closer than I have might have some idea about this question. If not, I may email IR, or just give up in disgust and sell - as expenses always seem to be ahead of revenue, and this may never change.
The quarterly of Q4FY23 speaks of sales won of $29m, $9m of which were to be recognised in FY23. The quarterly of Q1FY24 speaks of contracted and scheduled renewal revenue of $33m for FY24. Would someone please tell me whether the $20m out of the $29m, which would presumably be recognised in FY24, is supposed to be additional to the $33m?
Thanks to anyone who can help.
- Forums
- ASX - By Stock
- ALC
- Ann: Quarterly Activities Report & Placement Announcement/App 4C
Ann: Quarterly Activities Report & Placement Announcement/App 4C, page-72
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALC (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
-0.001(0.88%) |
Mkt cap ! $75.20M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.5¢ | $54.61K | 974.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 177104 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 125306 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 177104 | 0.056 |
7 | 589614 | 0.055 |
8 | 988015 | 0.054 |
1 | 10000 | 0.052 |
7 | 271407 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 125306 | 1 |
0.058 | 2550 | 1 |
0.059 | 50860 | 1 |
0.060 | 452578 | 4 |
0.061 | 49190 | 1 |
Last trade - 15.40pm 21/10/2024 (20 minute delay) ? |
Featured News
ALC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online